Trial intelligence / Profile preview

Sensory-Mechanical Responses to EVH and Mannitol in Cough Variant Asthma and Chronic Cough

NCT03105843Phase 4Completed

Start
Mar 2022
Primary completion
Jul 2026
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Bronchitol in cough variant asthma (CVA) and chronic cough (3 arms). Primary endpoint: Mid expiratory flows. Started Mar 2022; status: completed.

02

Drugs

Bronchitol
03

Conditions

cough variant asthma (CVA)chronic cough

Beyond the preview

Go deeper on NCT03105843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03105843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call